Health services use by children identified as heterozygous hemoglobinopathy mutation carriers via newborn screening

BACKGROUND: Newborn screening (NBS) for sickle cell disease incidentally identifies heterozygous carriers of hemoglobinopathy mutations. In Ontario, Canada, these carrier results are not routinely disclosed, presenting an opportunity to investigate the potential health implications of carrier status...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Pediatr
Autors principals: Khangura, Sara D., Potter, Beth K., Davies, Christine, Ducharme, Robin, Bota, A. Brianne, Hawken, Steven, Wilson, Kumanan, Karaceper, Maria D., Klaassen, Robert J., Little, Julian, Simpson, Ewurabena, Chakraborty, Pranesh
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2021
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8247172/
https://ncbi.nlm.nih.gov/pubmed/34210267
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12887-021-02751-8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars